| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/31/2007 | US7250399 Compounds having growth hormone releasing activity |
| 07/31/2007 | US7250285 Isolated nucleic acid; screening for antibacterial compounds |
| 07/31/2007 | US7250279 Human pyruvate dehydrogenese phosphatase |
| 07/31/2007 | US7250173 helminths obtained from preparatory animals raised in a specific human pathogen-free environment used to treat an excessive immune response including an aberrant/enhanced Th1 response, e.g., Crohn's disease and ulcerative colitis |
| 07/31/2007 | US7250168 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome |
| 07/31/2007 | US7250165 Anti-TNF antibodies, compositions, methods and uses |
| 07/31/2007 | US7250161 Equine GM-CSF |
| 07/31/2007 | CA2412596C Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/31/2007 | CA2398353C Anticancer compound and enantiomer separation method useful for synthesizing said compound |
| 07/31/2007 | CA2333603C New dipeptidyl peptidase iv effectors |
| 07/31/2007 | CA2270964C Benzonaphthyridines as bronchial therapeutics |
| 07/31/2007 | CA2260584C Androsterone derivatives for inhibiting dna binding of ap-1 and airway smooth muscle proliferation |
| 07/31/2007 | CA2100745C Amylin agonist peptides and uses therefor |
| 07/31/2007 | CA2085469C Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons |
| 07/31/2007 | CA2077763C Use of leukaemia inhibitory factor for regulating neuron development and maintenance |
| 07/31/2007 | CA1341537C Production of pluripotent granulocyte colony-stimulating factor |
| 07/26/2007 | WO2007083689A1 Plasminogen activator inhibitor-1 inhibitor |
| 07/26/2007 | WO2007083603A1 Therapeutic agent |
| 07/26/2007 | WO2007082470A1 Pyrrolo-pyridazine derivatives,their preparation methods and uses |
| 07/26/2007 | WO2007082425A1 A chinese medicine composition and its process and use |
| 07/26/2007 | WO2007059116A3 Geldanamycin derivatives and pharmaceutical compositions thereof |
| 07/26/2007 | WO2007047718A3 Generation and use of vasculogenic tumors |
| 07/26/2007 | WO2007025274A3 Self-assembling nanoparticles for the treatment of vascular diseases |
| 07/26/2007 | WO2007008541A3 Cellular cholesterol absorption modifiers |
| 07/26/2007 | WO2006122154A3 Pyridone derivatives for modulating stress-activated protein kinase system |
| 07/26/2007 | US20070174926 Sperm factor oscillogenin |
| 07/26/2007 | US20070174922 Nucleic acid encoding novel type-1 cytokine receptor glm-r |
| 07/26/2007 | US20070173534 Pyridinic sulfonamide derivatives method of production and use thereof |
| 07/26/2007 | US20070173525 Receptor or non-receptor types; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, agents; retinal vascularization |
| 07/26/2007 | US20070173491 Substituted lactams as inhibitors of Abeta protein production |
| 07/26/2007 | US20070173466 Methods of treating inflammatory diseases associated with bone destruction |
| 07/26/2007 | US20070173457 Tau-conotoxin peptides |
| 07/26/2007 | US20070173454 Administering an agent that decreases or regulates the blood level, production, function or activity of gonadotropins-leutinizing hormone, follicle stimulating hormone, activin or follistatin; parkinson's disease |
| 07/26/2007 | US20070173453 Methods of preventing or treating brain ischemia or brain injury |
| 07/26/2007 | US20070173436 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/26/2007 | US20070172892 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 07/26/2007 | US20070172532 Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2 |
| 07/26/2007 | US20070172499 Immunotherapy for humans |
| 07/26/2007 | US20070172467 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin |
| 07/26/2007 | US20070172450 Modulation of immune response and methods based thereon |
| 07/26/2007 | US20070172447 Agent for preventing and/or treating tissue disruption-accompanied diseases |
| 07/26/2007 | DE10303229B4 Ambroxol und Inhibitoren des Angiotensin Converting-Enzyms (ACE) umfassende Arzneimittel Arzneimittel-Zubereitung und ihre Verwendung zur Behandlung von neurodegenerativen Erkrankungen Ambroxol and inhibitors of the angiotensin converting enzyme (ACE) pharmaceutical compositions comprising drug preparation and their use for the treatment of neurodegenerative diseases |
| 07/25/2007 | EP1811035A1 Aspartic proteinase 2 (ASP2) |
| 07/25/2007 | EP1811033A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 07/25/2007 | EP1811025A1 Mutated amyloid protein |
| 07/25/2007 | EP1811020A1 Escherichia coli phytase |
| 07/25/2007 | EP1810715A2 Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity |
| 07/25/2007 | EP1810693A2 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions |
| 07/25/2007 | EP1810691A2 Immunotherapy for reversing immune suppression |
| 07/25/2007 | EP1810674A1 Stable pharmaceutical composition containing carisoprodol and meloxicam |
| 07/25/2007 | EP1810671A1 Agent for recovery from cerebral fatigue |
| 07/25/2007 | EP1809615A2 Lamotrigine analogs |
| 07/25/2007 | EP1809381A2 Use of compounds for the prevention of drug-induced cell toxicity |
| 07/25/2007 | EP1809297A1 Imidazo[1,5a]triazolo[1,5d]benzodiazepine derivatives for the treatment of cognitive disorders |
| 07/25/2007 | EP1809278A2 Combinations of pkc activators and pkc inhibitors for for alzheimer's disease treatment and cognitive enhancement |
| 07/25/2007 | EP1534346A4 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues |
| 07/25/2007 | EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 07/25/2007 | EP1444236B1 Separation of regioisomers of metal phthalocyanines |
| 07/25/2007 | EP1397364B1 Novel pyrrole derivatives as pharmaceutical agents |
| 07/25/2007 | EP1397130B1 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 07/25/2007 | EP1383502A4 Compounds and methods for the treatment of urogenital disorders |
| 07/25/2007 | EP1365765B1 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment |
| 07/25/2007 | EP1263763B1 Tubulin binding ligands |
| 07/25/2007 | EP1212621B1 Screening for agents modulating tgf-beta cell signalling |
| 07/25/2007 | EP1175508B1 Optical probes and assays for measuring protein phosphorylation |
| 07/25/2007 | EP1143985B1 Use of lactobacillus salivarius |
| 07/25/2007 | EP1071419B1 Cannabinoids as antioxidants and neuroprotectants |
| 07/25/2007 | EP1056462B1 Use of rhamnolipids as cosmetics |
| 07/25/2007 | EP1042365B1 Compounds and methods for modulating occludin related tissue permeability |
| 07/25/2007 | EP1005465B1 New epothilone derivatives, method for producing same and their pharmaceutical use |
| 07/25/2007 | EP0824546B1 Angiostatin fragments and methods of use |
| 07/25/2007 | CN1328376C Vascular endothelial cell growth factor variants and use thereof |
| 07/25/2007 | CN1328285C Inhibitor of stem cell proliferation and uses thereof |
| 07/25/2007 | CN1328279C Viral inhibitors |
| 07/25/2007 | CN1328260C Beta crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 07/25/2007 | CN1328259C Alpha crystalline form of perindopril tert-butyllamine salt |
| 07/25/2007 | CN1328258C Gamma crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 07/25/2007 | CN1327899C Gene recombined medicine of adenovirus carrier and p53 gene for treating proliferative diseases |
| 07/25/2007 | CN1327898C Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 07/25/2007 | CN1327860C Prepared Chinese medicine for treating yang disease of boil caused by accumulated noxious heat |
| 07/25/2007 | CN1327859C Schisandra fruit extractive, its preparation process and purposes |
| 07/25/2007 | CN1327838C Vitamin C oral disintegration tablet and its preparing method |
| 07/25/2007 | CN1327837C Medicine of total coumarins from dried fruits for treating allergic skin disease |
| 07/25/2007 | CN1327827C Coated granules based on angiotensin-converting enzyme inhibitor |
| 07/25/2007 | CN101003538A [1,4]diazocino[7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |
| 07/25/2007 | CN101003528A Diterpene compound and derivative in kaurene class of new disymmetry |
| 07/25/2007 | CN101002934A Compound cardiografin slow-releasing preparation for treating posto-lymphatic fistula and pancreas fistula, and its preparing method |
| 07/25/2007 | CN101002903A Oral traditional Chinese medicine for treat upper-jiao damp-heat type night sweat disease |
| 07/25/2007 | CN101002902A Oral traditional Chinese medicine for treating middle-jiao damp-heat type night sweat disease |
| 07/25/2007 | CN101002898A Medicine for treating hyperidrosis |
| 07/25/2007 | CN101002881A Oral traditional Chinese medicine for treating hemiplegia type hemidrosis |
| 07/25/2007 | CN101002872A Oral traditional Chinese medicine for treating anemic hemidrosis |
| 07/25/2007 | CN101002862A Medicine used for traditional Chinese medical moxibustion therapy, and its preparing method |
| 07/25/2007 | CN101002853A Oral medicine for treating cephalagra type hemidrosis |
| 07/25/2007 | CN101002820A Soaking type medicine for treating hidrosis of hands and feet, and its preparing method |
| 07/25/2007 | CN101002780A New pharmaceutical compositions containing flibanserin polymorph a |
| 07/25/2007 | CN101002734A Preparation of superfine powder containing anerthol trithione |
| 07/24/2007 | US7247734 In which the 3-phenyl group is 2,4-dihydroxy-substituted, e.g., 4-[5-bromo-4-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-6-chloro-benzene-1,3-diol; heat shock protein 90 inhibitors |
| 07/24/2007 | US7247728 Bicyclic N-arylamides |
| 07/24/2007 | US7247703 Anticancer agents; protein complex |